Non-invasive gene delivery across the blood-spinal cord barrier (BSCB) remains a challenge for treatment of spinal cord injury and disease. Here, we demonstrate the use of magnetic resonance image-guided focused ultrasound (MRIgFUS) to mediate non-surgical gene delivery to the spinal cord using self-complementary adeno-associated virus serotype 9 (scAAV9). scAAV9 encoding green fluorescent protein (GFP) was injected intravenously in rats at three dosages: 4 × 10 8, 2 × 10 9 and 7 × 10 9 vector genomes per gram (VG g -1). MRIgFUS allowed for transient, targeted permeabilization of the BSCB through the interaction of focused ultrasound (FUS) with systemically injected Definity lipid-shelled microbubbles. Viral delivery at 2 × 10 9 and 7 × 10 9 VG g -1 leads to robust GFP expression in FUS-targeted regions of the spinal cord. At a dose of 2 × 10 9 VG g -1, GFP expression was found in 36% of oligodendrocytes, and in 87% of neurons in FUS-treated areas. FUS applications to the spinal cord could address a long-term goal of gene therapy: delivering vectors from the circulation to diseased areas in a non-invasive manner.
|Original language||English (US)|
|Number of pages||10|
|State||Published - Jul 3 2015|
ASJC Scopus subject areas
- Molecular Medicine
- Molecular Biology